VILDAGLIPTIN 50mg. IP + METFORMIN 1000mg. IP

A potent antidiabetic agent for use in the treatment of type 2 diabetes. A potential drug for the management of patients with type 2 diabetes that is inadequately controlled with monotherapy. (Jamie D Croxtall, 2008) A beneficial agent in the management of hyperglycemia in patients with Type 2 diabetes. (Ved & Shah, 2012) A safe, and promising opportunity for assuring satisfactory glycemic control in Type 2 diabetes patients with impaired renal function. (Eleonora Russo, 2013) A valid option for ensuring glycemic control while avoiding bodyweight gain and reducing the risk of hypoglycemia. (Eleonora Russo, 2013) Shows statistically significant reductions in both fasting and postprandial glucose levels.(Eleonora Russo, 2013) A very efficacious drug for improving glycemic control in a wide range of Type 2 diabetes patients. (Chantal Mathieu, 2008)